Climb Bio, Inc.
CLYM- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001768446
In the last 90 days, Climb Bio, Inc. insiders filed 0 open-market purchases and 1 sale; 108 institutions reported holding it in 13F filings for Q2 2026, worth $734.3M in total; no superinvestor holds it.
13F holders, Q1 2022
Institutional positions in Climb Bio, Inc. as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 43
- +8 vs. Q4 2021
- Shares held
- 17.5M
- +125.7K (+0.7%) vs. Q4 2021
- Total value
- $146.8M
- −$35.0M (−19.3%) vs. Q4 2021
- New holders
- 11
- 6 more added
- Sold out
- 3
- 19 more reduced
Compare with Q4 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CLYM on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 108 | $734.3M |
| Q1 2026 | 80 | $221.2M |
| Q4 2025 | 65 | $157.4M |
| Q3 2025 | 68 | $89.7M |
| Q2 2025 | 69 | $61.9M |
| Q1 2025 | 76 | $63.4M |
| Q4 2024 | 80 | $100.3M |
| Q3 2024 | 71 | $278.2M |
| Q2 2024 | 47 | $354.8M |
| Q1 2024 | 21 | $46.2M |
| Q4 2023 | 23 | $45.5M |
| Q3 2023 | 23 | $44.0M |
| Q2 2023 | 22 | $46.8M |
| Q1 2023 | 19 | $48.4M |
| Q4 2022 | 20 | $61.0M |
| Q3 2022 | 22 | $47.8M |
| Q2 2022 | 29 | $45.7M |
| Q1 2022 | 43 | $146.8M |
| Q4 2021 | 35 | $181.8M |
| Q3 2021 | 32 | $310.7M |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2022
Shares, value and share of portfolio for each institution holding Climb Bio, Inc.; share changes are against Q4 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| FMR LLC | 94 | $1.00K | 0.00% | +94 | New |
| Point72 Hong Kong Ltd | 170 | $1.00K | 0.00% | +170 | New |
| Royal Bank of Canada | 370 | $3.00K | 0.00% | −1,233−76.9% | Reduced |
| Citigroup Inc | 424 | $4.00K | 0.00% | −1,335−75.9% | Reduced |
| Legal & General Group Plc | 659 | $5.00K | 0.00% | 00.0% | Unchanged |
| Ameritas Investment Partners, Inc. | 541 | $5.00K | 0.00% | 00.0% | Unchanged |
| Cubist Systematic Strategies, LLC | 638 | $5.00K | 0.00% | +638 | New |
| Amalgamated Bank | 1,039 | $9.00K | 0.00% | +1,039 | New |
| Amalgamated Financial Corp. | 1,039 | $9.00K | 0.00% | +1,039 | New |
| Bank of America Corp | 1,539 | $13.0K | 0.00% | −2,760−64.2% | Reduced |
| STRS Ohio | 1,600 | $13.0K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 1,616 | $14.0K | 0.00% | −2,822−63.6% | Reduced |
| Allspring Global Investments Holdings, LLC | 2,400 | $20.0K | 0.00% | −480−16.7% | Reduced |
| Tower Research Capital LLC (TRC) | 2,431 | $20.0K | 0.00% | +1,430+142.9% | Added |
| California State Teachers Retirement System | 2,593 | $22.0K | 0.00% | −1,220−32.0% | Reduced |
| JPMorgan Chase & Co | 2,829 | $24.0K | 0.00% | −205,199−98.6% | Reduced |
| Barclays PLC | 2,850 | $24.0K | 0.00% | +2,850 | New |
| American International Group, Inc. | 2,995 | $25.0K | 0.00% | −755−20.1% | Reduced |
| New York State Common Retirement Fund | 3,359 | $28.0K | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 3,718 | $31.0K | 0.00% | −2,706−42.1% | Reduced |
| Deutsche Bank AG | 3,841 | $32.0K | 0.00% | −452−10.5% | Reduced |
| Morgan Stanley | 5,682 | $47.0K | 0.00% | −4,440−43.9% | Reduced |
| Chicago Partners Investment Group LLC | 22,209 | $81.0K | 0.01% | +9,723+77.9% | Added |
| Stifel Financial Corp | 10,157 | $85.0K | 0.00% | +10,157 | New |
| Bank of New York Mellon Corp | 13,893 | $117.0K | 0.00% | −162−1.2% | Reduced |
| Qube Research & Technologies Ltd | 15,874 | $133.0K | 0.00% | +15,874 | New |
| Charles Schwab Investment Management Inc | 16,001 | $135.0K | 0.00% | −1,223−7.1% | Reduced |
| Bridgeway Capital Management, LLC | 18,400 | $154.0K | 0.00% | +18,400 | New |
| Parkwood LLC | 41,133 | $345.0K | 0.06% | +10,524+34.4% | Added |
| Tudor Investment Corp Et Al | 46,092 | $387.0K | 0.01% | −149,366−76.4% | Reduced |
| Northern Trust Corp | 55,581 | $466.0K | 0.00% | −5,714−9.3% | Reduced |
| Silverarc Capital Management, LLC | 88,279 | $741.0K | 0.40% | +88,279 | New |
| State Street Corp | 95,070 | $798.0K | 0.00% | +1,991+2.1% | Added |
| Hudson Bay Capital Management LP | 100,000 | $839.0K | 0.01% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 113,021 | $948.0K | 0.00% | −2,651−2.3% | Reduced |
| Point72 Asset Management, L.P. | 142,333 | $1.19M | 0.01% | +142,333 | New |
| Goldman Sachs Group Inc | 165,087 | $1.39M | 0.00% | +964+0.6% | Added |
| Monashee Investment Management LLC | 227,201 | $1.91M | 0.55% | −72,799−24.3% | Reduced |
| Vanguard Group Inc | 304,798 | $2.56M | 0.00% | −1,557−0.5% | Reduced |
| BlackRock Inc. | 339,345 | $2.85M | 0.00% | −17,099−4.8% | Reduced |
| Woodline Partners LP | 373,368 | $3.13M | 0.05% | 00.0% | Unchanged |
| Samlyn Capital, LLC | 2,130,237 | $17.9M | 0.27% | +426,691+25.0% | Added |
| Ra Capital Management, L.P. | 13,150,849 | $110.3M | 2.41% | 00.0% | Unchanged |
| Caas Capital Management LP | 0 | $0 | 0.00% | −75,000−100.0% | Sold out |
| Parametric Portfolio Associates LLC | 0 | $0 | 0.00% | −47,191−100.0% | Sold out |
| Old Well Partners, LLC | 0 | $0 | 0.00% | −10,300−100.0% | Sold out |